Skincare's New Goal: Slow Aging at the Cellular Level
By @sharedot · · 6 pages
- Beauty
- Skincare Science
- Pro Longevity
- Peptides
A pro-longevity skincare wave targets senescent 'zombie cells,' with OneSkin claiming its OS-01 peptide reverses skin's biological age.
The Shift From Anti-Aging to Pro-Longevity
LA Times Studios reports that a new generation of skincare brands is targeting the biological processes behind aging rather than just wrinkles, moving past the reactive formulas and marketing of the traditional anti-aging industry.
The outlet notes the longevity and preventive wellness market is anticipated to reach $1,868.2 billion by 2034, with skin and aesthetics expected to hold a $107.6 billion share.
Dr. Wong, Head of Dermal Aesthetics at SHA Wellness Clinic in Mexico, tells the publication that pro-longevity skincare aims to preserve how well skin functions over time by supporting the barrier, collagen architecture, cellular repair and resilience against UV, pollution and chronic inflammation.
The goal, he says, is not 'ageless' skin but skin that stays healthy and functional for as long as possible.
Why 'Zombie Cells' Are the Surprising Target
According to OneSkin co-founders Carolina Reis Oliveira, PhD, and Alessandra Zonari, PhD, some cells stop dividing as we age but remain active, releasing inflammatory signals that damage surrounding healthy cells and accelerate tissue aging — the so-called 'zombie cells.'
They tell the outlet these changes begin as early as the mid-20s and 30s, long before wrinkles appear. The founders add that they believe 'anti-aging' is a fundamentally flawed term, arguing the aim is not to fight aging but to change how we experience it.
The Evidence Behind OS-01
According to the Los Angeles Times report, OneSkin screened more than 900 peptides over five years before developing OS-01, which it describes as the first ingredient scientifically validated to reduce skin's biological age in experimental human skin models.
The outlet cites a 2023 study showing OS-01 reduced markers of cellular senescence, plus a split-face trial comparing OS-01 FACE against an identical formula without the peptide.
It also reports a 12-week randomized controlled study of 60 women aged 60–90, in which OS-01 BODY improved skin barrier function by 41% and hydration by 38%, with 70% of users reporting appearance improvements versus 42% in the control group, alongside reduced IL-8, an inflammatory marker associated with aging.
Experts Urge Caution — and Personalization Is Riding the Same Wave
The enthusiasm is not without skeptics.
Dr. Wong tells LA Times Studios that peptides currently have the greatest practical potential for topical use, but that their effects depend on the specific peptide, concentration, stability and skin penetration — and they have not been shown to outperform established ingredients like retinol and daily photoprotection.
He adds there is insufficient evidence that exosomes or stem-cell-derived materials retain biological activity in conventional home products.
Separately, Business News This Week reports that ingredient transparency and science-backed formulation are becoming trust drivers in the parallel personalized skincare boom, with consumers scrutinizing labels and brands being warned to avoid claiming cosmetics can diagnose or treat medical skin conditions.